HOME >> MEDICINE >> NEWS
Now Is Time To Design Brain-Saving Drugs Specifically For Children, UCSF Neurologist Says

When it comes to brain disorders, the standard method used to find a drug for children is upside down, says Donna Ferriero, MD, chief of pediatric neurology at Lucile Packard Children's Health Services at UCSF. New drug therapies typically are designed for adults and tested on them. Studies to find out if the drug can be used for children usually are limited to finding the right, scaled-down child-size dose.

It is time that children got their own treatments, Ferriero writes in an editorial in the December 1998 issue of Current Opinion in Pediatrics. She says that scientists now have enough information about young children's developing brains to start looking for appropriate therapies specifically targeted at childhood neurological disorders.

Her editorial introduces five scientific articles on different brain disorders, bound together by new knowledge about how they cause brain injury. An international conference slated for December 8-9 in Washington, D.C. will focus on interventions that might work against one of the most common causes of brain damage, perinatal asphyxia, where a newborn is accidentally deprived of oxygen and blood flow during birth.

The scientists are spurred partly by the history of adult drugs used on children -- some are ineffective, some have unexpected results, some even cause the opposite effect that they have in adults. But Ferriero says the most compelling reason for child-specific treatment is the growing body of evidence that a young child's nervous system is not a miniature version of an adult's. From before birth throughout the first decade of life, the brain continues to develop and change, as some neurons grow and make connections and others are pared away. When children's brains are damaged by a disease or an accident, the effect can be widespread, because the injury can alter a whole stage of brain development.

That also means that drugs must be designed to avoid damaging the developing brain. An ideal drug
'"/>

Contact: Janet Basu
janbasu@itsa.ucsf.edu
415-476-2557
University of California - San Francisco
1-Dec-1998


Page: 1 2 3 4

Related medicine news :

1. Designing an ultrasensitive optical nose for chemicals
2. Views Of Tamoxifen And Synthetic Estrogen In Action Provide Clues For Designing Better Drugs
3. New Study Designed To Improve Outcomes In Women With Metastatic Breast Cancer
4. X-ray Microscope Designed To Study Jet Engine Components Now Probes Tooth Dentin
5. Duke Obtains FDA Designation For Pompe Disease Therapy
6. DNA Imaging to Design Better Drugs
7. Drugs used to treat Alzheimers in nursing homes are worsening sufferers illness
8. Drugs aid weight loss among type 2 diabetes patients
9. Drugs experts call for government backing to stop the spread of hepatitis C
10. Drugs may not be best weapon against teen migraines, study finds
11. Drugs and stress management together best manage chronic tension headache: Clinical trial proves benefit of combined therapies

Post Your Comments:
(Date:5/25/2013)... York (PRWEB) May 25, 2013 ... litigation underway in U.S. District Court, Western District of ... According to a Case Management Order issued on ... the filing of contested motions in the Actos bladder ... motions. (In re: Actos Product Liability Litigation, MDL No. ...
(Date:5/25/2013)... The report “Global Food Encapsulation Market (2012 – ... Materials, Packaging, & Geography: Trends & Forecasts” defines ... analysis and forecasting of the global revenue for ... restraining factors for the global food encapsulation markets ... market is segmented and revenue are forecasted on ...
(Date:5/25/2013)... 25, 2013 Providing patients with their best ... team of weight management professionals. But, aside from educating patients ... Diet Doc’s hCG diets also provide patients, who ... childhood like bullying, more control over their lives by achieving ... with the underlying factors of weight gain derived from earlier ...
(Date:5/25/2013)... New York, New York (PRWEB) May 25, 2013 ... patients who allegedly suffered serious, life-threatening episodes of internal bleeding ... federal litigation underway in U.S. District Court, Southern District of ... on the Court’s website, 818 Pradaxa side effect claims had ... 24, 2013. That’s up from 705 claims reported by ...
(Date:5/25/2013)... New York, NY (PRWEB) May 25, 2013 ... organization dedicated to brain cancer research and advocacy, comments ... for Extraterrestrial Physics, that shows incorporating cold atmospheric plasma ... glioblastoma cells. , According to a Science ... for Extraterrestrial Physics (MPE), biologists and physicians demonstrated the ...
Breaking Medicine News(10 mins):Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2
(Date:5/23/2013)... , May 23, 2013 Nephros, Inc. ... stage medical device company that develops and sells high ... of its rights offering.  In addition, the concurrent temporary ... warrants expired on May 17, 2013. Nephros ... million from the rights offering.   A portion of the ...
(Date:5/23/2013)... -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a ... intellectual property developed and owned by Hadassah University ... research center, today announced that its portfolio company, ... the Israeli Ministry of Industry and Commerce, Office ... development and advance clinical trials. Cell Cure,s development ...
(Date:5/23/2013)... 2013  Texas, premier physician associations today announced the ... tools they need to provide demonstrably better and more ... marketplace. "I am confident the Physician Services ... Stephen L. Brotherton , MD, president ... doctors are determined to make health care ...
Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4
Cached News: